Background Information
Technology to administer parenteral nutrition in
the homecare setting was first developed during
the late 1960s and early 1970s to meet the need
for life-saving and supportive intravenous
nutrition therapy.[1]
[3]
[4] Home parenteral nutrition
therapy has now been conducted safely and
effectively for more than 25 years.[5]
[6]
[7]
The infusion of nutrients directly into the
bloodstream provides nutrition support to
patients who are malnourished or at risk for
becoming malnourished and are unable to maintain
nutritional status through oral and/or enteral
feeding. Formulations typically include
carbohydrate (dextrose), protein (amino acids),
fat emulsions, electrolytes and micronutrients
(vitamins, minerals, trace elements).
Intravenous nutrition support can be provided
peripherally or centrally.
Peripheral parenteral nutrition (PPN)
support for longer periods of time can be
problematic. Generally, peripheral parenteral
nutrition support is provided for short periods
of time to lower at- risk patients who are not
severely malnourished and can tolerate larger
fluid loads. Calories and other nutrients may be
less complete because a lower osmolarity (less
than 900 mOsm/L) is required to safely provide
nutrients through a peripheral vein. In order to
provide adequate amounts of nutrients, a larger
volume of hyperosmolar fluids is required, often
including fat emulsions.
TPN is generally delivered into the superior
vena cava, which allows for higher
concentrations of nutrients and for prolonged
therapy (weeks to years in duration).
Indications for TPN include: an inability to
orally or enterally meet nutritional needs due
to malabsorption, the need for bowel rest, or
conditions that prohibit adequate oral or
enteral feeding for more than seven days. In
cases of critical illness where hypermetabolism
is expected to continue for more than four to
five days, parenteral nutrition can be
initiated.
In
addition to treatment for malnutrition, TPN can
be used as a preventive therapy. For instance,
pre-surgical support for patients with
pre-existing malnutrition may improve outcomes.
Cancer patients who experience treatment-related
gastrointestinal toxicity may be able to prevent
problems associated with nutritional decline if
TPN is initiated early.
----------------------------
[2] Dudrick SJ,
Wilmore DW, Vars HM, Rhoads JE. Can
intravenous feeding as the sole means of
nutrition support growth in the child
and resore weight loss in an adult? An
affirmative answer. Ann Surg.
1969;169(6):974-984.
[3] Broviac JW, Cole
JJ, Scribner BH. A silicone rubber
atrial catheter for prolonged parenteral
alimentation. Surg Gynecol Obstet.
1973;136(4):602-606.
[4] Langer B, McHattie
JD, Zohrab WJ, Jeejeebhoy KN. Prolonged
survival after complete small bowel
resection using intravenous alimentation
at home. J Surg Res. 1973;15(3):226-233.
[5] Jeejeebhoy KN,
Zohrab WJ, Langer B, Phillips MJ, Kuksis
A, Anderson GH. Total parenteral
nutrition at home for 23 months, without
complication, and with good
rehabilitation. A study of technical and
metabolic features. Gastroenteraology.
1973;65(5):811-820.
[6] Shils ME. A
program for total parenteral nutrition
at home. Am J Clin Nutr.
1975;28(12)1429-1435.
[7] Bordos DC, Cameron
JL. Successful long-term intravenous
hyperalimentation in the hospital and at
home. Arch Surg. 1975;110(4):439-441.